Follow-Up After Starting Contraception
No routine follow-up visit is required after initiating contraception for healthy women, though patients should be advised to return at any time to discuss side effects, concerns, or method changes. 1
General Follow-Up Recommendations
The CDC's U.S. Selected Practice Recommendations establish that routine scheduled follow-up visits are not necessary after contraceptive initiation for any method—including IUDs, implants, injectables, combined hormonal contraceptives (CHCs), or progestin-only pills. 1 This applies to healthy women in general situations, though specific populations may benefit from closer monitoring. 1
Populations That May Benefit From Earlier Follow-Up
While not required, consider scheduling follow-up for:
- Adolescents: A visit at 1-3 months after initiating combined oral contraceptives is useful for addressing persistent adverse effects or adherence issues. 1
- Women with certain medical conditions or characteristics 1
- Women with multiple medical conditions 1
What to Address at Any Follow-Up Encounter
When you do see patients using contraception (whether scheduled or unscheduled), assess the following:
- Satisfaction with the method and any concerns about use 1
- Changes in health status or medications that would affect medical eligibility (U.S. MEC category 3 or 4 conditions) 1
- Weight changes for all methods, particularly for DMPA users where early weight gain (>5% baseline weight within 6 months) predicts continued weight gain 1
- Blood pressure for combined hormonal contraceptive users only 1
- IUD string presence for IUD users (consider checking) 1
Method-Specific Considerations
Injectable Contraceptives (DMPA)
- No routine follow-up visit required 1
- Advise return for reinjection timing 1
- Weight monitoring is particularly important, as early weight gain predicts future significant weight gain 1
Combined Hormonal Contraceptives
- Adolescents benefit from a 1-3 month follow-up to address transient side effects (irregular bleeding, headache, nausea) and adherence issues 1
- The CDC recommends prescribing up to 1 year of contraceptives at a time 1
IUDs and Implants
Evidence on Follow-Up Effectiveness
The evidence supporting routine follow-up visits is weak. A systematic review found it difficult to determine what effect, if any, follow-up visits or contacts have on contraceptive continuation or correct use. 2 The few studies identified were of poor quality, not method-specific, and had poor compliance rates. 2
However, research shows that early discontinuation is common—nearly half of women switch or discontinue within the first year, with side effects being the primary reason (73% of those who stopped). 3 One older study found that 46% of women discontinued oral contraceptives due to side effects within 6 months. 4
Clinical Pitfalls to Avoid
The most critical intervention is counseling at initiation, not scheduled follow-up. Emphasize:
- Common transient side effects and that most will resolve 4
- The importance of returning at any time for concerns 1
- Backup method identification 4
- Adherence strategies (smartphone reminders, family support) 1
Do not create barriers by requiring follow-up visits before providing extended supplies. The CDC explicitly recommends prescribing up to 1 year of contraceptives at initiation. 1